Mitochondrial-Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Mitochondrial-Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy.
- Published In:
- Advanced healthcare materials, e71003 (2026)
- Authors:
- Zhou, Biyu, Feng, Nana, Xiao, Jian, Huang, Qingqing, Li, Qiushi, Zhang, Zhanzhan, Liu, Yang
- Database ID:
- RPEP-16602
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16602APA
Zhou, Biyu; Feng, Nana; Xiao, Jian; Huang, Qingqing; Li, Qiushi; Zhang, Zhanzhan; Liu, Yang. (2026). Mitochondrial-Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy.. Advanced healthcare materials, e71003. https://doi.org/10.1002/adhm.71003
MLA
Zhou, Biyu, et al. "Mitochondrial-Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy.." Advanced healthcare materials, 2026. https://doi.org/10.1002/adhm.71003
RethinkPeptides
RethinkPeptides Research Database. "Mitochondrial-Disrupting Antimicrobial Peptide Nanoparticles..." RPEP-16602. Retrieved from https://rethinkpeptides.com/research/zhou-2026-mitochondrialdisrupting-antimicrobial-peptide-nanoparticles
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.